Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00263 USD | +9.58% | 0.00% | -70.11% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
Chart calendar Endonovo Therapeutics, Inc.
Upcoming events on Endonovo Therapeutics, Inc.
Past events on Endonovo Therapeutics, Inc.
2023-08-20 | Q2 2023 Earnings Release |
2023-03-09 04:30 pm | Shareholders Meeting |
2022-11-20 | Q3 2022 Earnings Release |
2020-08-20 02:51 pm | Interim 2020 Earnings Release |
2020-06-15 08:00 am | Q1 2020 Earnings Release |
2020-05-04 08:15 am | FY 2019 Earnings Release |
2019-08-13 01:39 pm | Interim 2019 Earnings Release |
2016-06-01 | Marcum Microcap Conference |
Annual results
Fiscal Period | December | 2018 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,08 |
EBITDA | Released Forecast Spread | 0,00 |
EBIT | Released Forecast Spread | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 |
Net income | Released Forecast Spread | 0,00 |
EPS USD | Released Forecast Spread | -20,0 |
Announcement Date | 15/04/19 |
Past sector events for Endonovo Therapeutics, Inc.
- Stock Market
- Equities
- ENDV Stock
- Calendar Endonovo Therapeutics, Inc.